Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low- density lipoprotein in kidney transplant recipients

Transplantation

Volumn 63, Issue 5, 1997, Pages 679-685

  Hussein, Osamah ^a,b   Rosenblat, Mira ^a   Refael, Gerrey ^a   Aviram, Michael ^a,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Rebecca Sieff Government Hospital   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2,2' AZOBIS(2 AMIDINOPROPANE); ALPHA TOCOPHEROL; COPPER SULFATE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SELENIUM; TRIACYLGLYCEROL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; HIGH RISK PATIENT; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RECIPIENT;

ADULT; CHOLESTEROL, LDL; COPPER SULFATE; DIET; ERYTHROCYTES; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; KIDNEY TRANSPLANTATION; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MIDDLE AGED; OXIDATION-REDUCTION; SELENIUM;

EID: 0030894549     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703150-00012     Document Type: Article

References (41)

1. Linder A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697.
2. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988; 84: 985.
3. Kasiske BL, Umen AJ. Persistent hyperlipidemia in renal transplant patients. Medicine 1987; 66: 309.
4. Cattran DC, Steiner G, Wilson DR, Fenton SSA. Hyperlipidemia after renal transplantation: natural history and pathophysiology. Ann Intern Med 1979; 91: 554.
5. Moore R, Thomas D, Morgan E, et al. Abnormal lipid and lipoprotein profiles following renal transplantation. Transplant Proc 1993; 25: 1060.
6. Anselmann G, Blank M, Baumann K. Cyclosporine A induced lipid peroxidation in microsomes and effect on active and passive glucose transport by brush border membrane vesicles of rat kidney. Res Commun Chem Pathol Pharmacol 1988; 62: 207.
7. Apanay DC, Neylan JF, Ragab MS, Sgoutas DS. Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients. Transplantation 1994; 58: 663.
8. Ghanem H, Van Den Dorpel MA, Weimar W, Man in'T Veld AJ, El-Kannishy MH, Jansen H. Increased low density lipoprotein oxidation 20 in stable kidney transplant recipients. Kidney Int 1996; 49: 488.
9. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol, modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med 1989; 320: 915.
10. Aviram M. Oxidative modification of low density lipoprotein and its relation to atherosclerosis. Isr Med Sci 1995; 31: 241.
11. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13: 341.
12. Aviram M. Modified forms of LDL and atherosclerosis. Atherosclerosis 1993; 98: 1.
13. Braun WE. Long-term complications of renal transplantation. Kidney Int 1990; 37: 1363.
14. Raine AE, Ledingham JG. Cardiovascular complications after renal transplantation. In: Morris PJ, ed. Kidney transplantation: principles and practice, 2nd ed. London: Grune and Stratton, 1984: 469.
15. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G. Ischemic heart disease - major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995; 60: 451.
16. Flohe L, Gunzler WA, Loschen G. The glutathione peroxidase reaction: a key to understand the selenium requirement of mammals. In: Kharasch N, ed. Trace metals in health and disease. New York: Raven Press, 1979: 263.
17. Toyoda H, Himeno S, Imura N. Regulation of glutathione peroxidase mRNA level by dietary selenium manipulation. Biochim Biophys Acta 1990; 1049: 213.
18. Baker RD, Baker SS, La Rosa K. Selenium regulation of glutathione peroxidase in human hepatoma cell line Hep3B. Arch Biochem Biophys 1993; 304: 53.
19. Flohe L. The selenoprotein glutathione peroxidase. In: Dolphin D, Poulson R, Avramovic O, eds. Glutathione: chemical, biochemical and medical aspects - part A. New York: Wiley and Sons, 1989: 644.
20. Salonen JT, Alfthan G, Pekkararnen J, Huttunen JK, Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982; 2: 175.
21. Salonen JT, Salonen R, Seppanen K, Kantola M, Suntioinen S, Korpela H. Interactions of serum copper, selenium and low density lipoprotein cholesterol in atherogenesis. BMJ 1991; 302: 756.
22. Girelli D, Olivieri O, Stanzial AM, et al. Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: relation to dialysis treatments, diet and cardiovascular complications. Clin Sci 1993; 84: 611.
23. Turan B, Delilbasi E, Dalay N, Sert S, Afrasyap L, Sayal A. Serum selenium and glutathione-peroxidase activities and their interaction with toxic metals in dialysis and renal transplantation patients. Biol Trace Elem Res 1992; 33: 95.
24. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85: 9748.
25. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302.
26. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jurgens G. A spectrophotometric assay of lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989; 30: 627.
27. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem Med 1983; 30: 111.
28. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low-density lipoprotein. Free Radic Res Commun 1989; 6: 67.
29. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 1968; 21 (suppl): 77.
30. Kokatnur VR, Jelling M. Iodometric determination of peroxygen in organic compounds. Am Chem Soc 1941; 63: 1432.
31. Beutler E. Effect of flavin compounds on glutathione reductase activity: in vivo and in vitro studies. J Clin Invest 1969; 48: 1957.
32. Griffith OW, Meister A. Excretion of cysteine and gamma-glutamyl cysteine moieties in human and experimental animal with gamma-glutamyl transpeptidase deficiency. Proc Natl Acad Sci USA 1980; 77: 3384.
33. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissues. Anal Biochem 1969; 27: 502.
34. Taylor JE, Scott N, Hill A, et al. Oxygen free radicals and platelet and granulocyte aggregability in renal transplant patients. Transplantation 1993; 55: 500.
35. Lavy A, Brook JG, Dankner G, Ben Amotz A, Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 1991; 40: 794.
36. Moser M, Winkler R, Huber E, Maier K. Changes in selenium status, antioxidant enzyme activity and lipid peroxide level after drinking cures in Bad Hall health resort. Wien Klin Wochenschr 1994; 106: 54.
37. Huang W, Akesson B. Radioimmunoassay of glutathione peroxidase in human serum. Clin Chim Acta 1993; 219: 139.
38. Kuzuya M, Naito M, Funaki C, Hayashi T, Asai K, Kuzuza F. Protective role of intracellular glutathione against oxidized low density lipoprotein in cultured endothelial cells. Biochem Biophys Res Commun 1989; 163: 1466.
39. Hoffman R, Brook GJ, Aviram M. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Atherosclerosis 1992; 93: 105.
40. Luoma PV, Stengard H, Korpeld H. Lipid peroxides, glutathione peroxidase, high density lipoprotein subfractions and apolipoproteins in young adults. J Int Med 1990; 227: 287.
41. Salonen JT. The role of lipid peroxidation, antioxidants and pro-oxidants in atherosclerosis. Acta Cardiol 1993; 48: 457.